dsdsa

product

Factory source Anti-Cancer Paclitaxel - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

carry on to boost, to guarantee products excellent in line with market and consumer standard specifications. Our enterprise has a quality assurance system are actually established for 57-83-0, Treatment Of Hepatitis C, 50700-72-6, We, with open arms, invite all interested buyers to visit our website or contact us directly for further information.
Factory source Anti-Cancer Paclitaxel - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai Detail:

Product name Cabazitaxel
Synonyms (αR,βS)-β-[[(1,1-DiMethylethoxy)carbonyl]aMino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-diMethoxy-4a,8,13,13-tetraMethyl-5-oxo-7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester
CAS No. 183133-96-2
Appearance White to almost white crystalline solid
Molecular Formula C45H57NO14
Molecular Weight 835.93
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Cabazitaxel CAS:183133-96-2

ITEMS STANDARDS RESULTS
CHARACTERISTICS White to almost white crystalline solid White crystalline solid
IDENTIFICATION Should to positive Positive
SOUBILITY Freely soluble in Acetone and Dichloromethane,Soluble in Ethanol and Methanol, Sparingly soluble in Ethyl acetate. Complies
LOSS ON DRYING ≤1.0% 0.1%
RESIDUE ON IGNITION ≤0.2% 0.05%
HEAVY METALS ≤20ppm Complies
RELATIVE SUBSTANCE Single impurity:≤0.3% 0.08%
Total Impurities:≤0.8 % 0.19%
RESIDUAL SOLVENT Tetrahydrofuran:≤0.072%Methanol: ≤0.3%

Dichloromethane:≤0.06%

Ethyl Acetate: ≤0.5%

Not DetectedNot Detected

Not Detected

Not Detected

ASSAY NLT 98.5% 99.78%
Conclusion:It complies to prescribed enterprise standard

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Factory source Anti-Cancer Paclitaxel - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

Factory source Anti-Cancer Paclitaxel - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

Factory source Anti-Cancer Paclitaxel - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures


Related Product Guide:

We now have a highly efficient crew to deal with inquiries from clients. Our intention is "100% shopper pleasure by our merchandise quality, price tag & our staff service" and take pleasure in a very good standing amongst purchasers. With quite a few factories, we can easily provide a wide vary of Factory source Anti-Cancer Paclitaxel - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai , The product will supply to all over the world, such as: Frankfurt, Poland, Juventus, "Make the women more attractive "is our sales philosophy. "Being customers' trusted and preferred brand supplier" is the goal of our company. We are strict with every part of our work. We sincerely welcome friends to negotiate business and start cooperation. We hope to join hands with friends in different industries to create a brilliant future.
  • The customer service staff's attitude is very sincere and the reply is timely and very detailed, this is very helpful for our deal,thank you.
    5 Stars By Murray from Japan - 2018.09.23 18:44
    In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
    5 Stars By Gwendolyn from Latvia - 2018.06.18 17:25
    Write your message here and send it to us